Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 27

1.

Risk of Hypotony in Juvenile Idiopathic Arthritis (JIA)-Associated Uveitis.

Moradi A, Stroh IG, Reddy AK, Hornbeak DM, Leung TG, Burkholder BM, Thorne JE.

Am J Ophthalmol. 2016 Jun 23. pii: S0002-9394(16)30299-9. doi: 10.1016/j.ajo.2016.06.026. [Epub ahead of print]

PMID:
27345732
2.

Occurrence of and Risk Factors for Ocular Hypertension and Secondary Glaucoma in Juvenile Idiopathic Arthritis-associated Uveitis.

Stroh IG, Moradi A, Burkholder BM, Hornbeak DM, Leung TG, Thorne JE.

Ocul Immunol Inflamm. 2016 Mar 22:1-10. [Epub ahead of print]

PMID:
27003850
3.

Peripheral Ulcerative Keratitis following Laser in situ Keratomileusis.

Burkholder BM, Kuo IC.

Case Rep Ophthalmol. 2016 Jan 8;7(1):9-15. doi: 10.1159/000443324. eCollection 2016 Jan-Apr.

4.

Dissociations of the Fluocinolone Acetonide Implant: The Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study.

Holbrook JT, Sugar EA, Burke AE, Vitale AT, Thorne JE, Davis JL, Jabs DA; Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group.

Am J Ophthalmol. 2016 Apr;164:29-36. doi: 10.1016/j.ajo.2015.12.028. Epub 2015 Dec 31.

PMID:
26748056
5.

The Dexamethasone Intravitreal Implant for Noninfectious Uveitis: Practice Patterns Among Uveitis Specialists.

Burkholder BM, Moradi A, Thorne JE, Dunn JP.

Ocul Immunol Inflamm. 2015;23(6):444-53. doi: 10.3109/09273948.2015.1070180. Epub 2015 Oct 30.

PMID:
26517764
6.

Vogt-Koyanagi-Harada disease.

Burkholder BM.

Curr Opin Ophthalmol. 2015 Nov;26(6):506-11. doi: 10.1097/ICU.0000000000000206. Review.

PMID:
26448042
7.

Factors Predicting Visual Acuity Outcome in Intermediate, Posterior, and Panuveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial.

Kempen JH, Van Natta ML, Altaweel MM, Dunn JP, Jabs DA, Lightman SL, Thorne JE, Holbrook JT; Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group.

Am J Ophthalmol. 2015 Dec;160(6):1133-1141.e9. doi: 10.1016/j.ajo.2015.09.017. Epub 2015 Sep 18.

PMID:
26386159
8.

Outcome of Treatment of Uveitic Macular Edema: The Multicenter Uveitis Steroid Treatment Trial 2-Year Results.

Tomkins-Netzer O, Lightman S, Drye L, Kempen J, Holland GN, Rao NA, Stawell RJ, Vitale A, Jabs DA; Multicenter Uveitis Steroid Treatment Trial Research Group.

Ophthalmology. 2015 Nov;122(11):2351-9. doi: 10.1016/j.ophtha.2015.07.036. Epub 2015 Sep 7.

PMID:
26359188
9.
10.

Benefits of Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study.

Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group, Kempen JH, Altaweel MM, Drye LT, Holbrook JT, Jabs DA, Sugar EA, Thorne JE.

Ophthalmology. 2015 Oct;122(10):1967-75. doi: 10.1016/j.ophtha.2015.06.042. Epub 2015 Aug 20.

PMID:
26298715
11.

Clinical features and incidence rates of ocular complications in patients with ocular syphilis.

Moradi A, Salek S, Daniel E, Gangaputra S, Ostheimer TA, Burkholder BM, Leung TG, Butler NJ, Dunn JP, Thorne JE.

Am J Ophthalmol. 2015 Feb;159(2):334-43.e1. doi: 10.1016/j.ajo.2014.10.030. Epub 2014 Nov 5.

PMID:
25447116
12.

Multiple serous retinal detachments seen on wide-field imaging in a patient with sympathetic ophthalmia.

Burkholder BM, Dunn JP.

JAMA Ophthalmol. 2014 Oct;132(10):1220. doi: 10.1001/jamaophthalmol.2014.52. No abstract available.

PMID:
25171189
13.

The prevalence and incidence of epiretinal membranes in eyes with inactive extramacular CMV retinitis.

Kozak I, Vaidya V, Van Natta ML, Pak JW, May KP, Thorne JE; Studies of the Ocular Complications of AIDS Research Group.

Invest Ophthalmol Vis Sci. 2014 Jun 12;55(7):4304-12. doi: 10.1167/iovs.14-14479.

14.

Cost-effectiveness of fluocinolone acetonide implant versus systemic therapy for noninfectious intermediate, posterior, and panuveitis.

Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group, Sugar EA, Holbrook JT, Kempen JH, Burke AE, Drye LT, Thorne JE, Louis TA, Jabs DA, Altaweel MM, Frick KD.

Ophthalmology. 2014 Oct;121(10):1855-62. doi: 10.1016/j.ophtha.2014.04.022. Epub 2014 Jun 5.

15.

Tattoo-associated uveitis.

Ostheimer TA, Burkholder BM, Leung TG, Butler NJ, Dunn JP, Thorne JE.

Am J Ophthalmol. 2014 Sep;158(3):637-43.e1. doi: 10.1016/j.ajo.2014.05.019. Epub 2014 May 27.

PMID:
24875002
16.

Intraocular tuberculosis presenting as a large anterior chamber mass.

Ostheimer TA, Dunn JP, Eberhart CG, Burkholder BM.

Ocul Immunol Inflamm. 2015 Feb;23(1):100-1. doi: 10.3109/09273948.2014.907434. Epub 2014 Apr 25. No abstract available.

17.

Clinical features and incidence rate of ocular complications in punctate inner choroidopathy.

Leung TG, Moradi A, Liu D, Nguyen QD, Dunn JP, Burkholder B, Butler NJ, Ostheimer T, Thorne JE.

Retina. 2014 Aug;34(8):1666-74. doi: 10.1097/IAE.0000000000000125.

PMID:
24743642
18.

Sclerouveitis associated with Rosai-Dorfman disease in an HIV-infected patient.

Monroe AK, Burkholder BM, Butler NJ, Duffield AS.

Ocul Immunol Inflamm. 2014 Jun;22(3):236-8. doi: 10.3109/09273948.2013.767914. Epub 2014 Feb 24.

PMID:
24564426
19.

Spectral domain optical coherence tomography findings in acute syphilitic posterior placoid chorioretinitis.

Burkholder BM, Leung TG, Ostheimer TA, Butler NJ, Thorne JE, Dunn JP.

J Ophthalmic Inflamm Infect. 2014 Jan 27;4(1):2. doi: 10.1186/1869-5760-4-2.

20.

Reply: To PMID 23219064.

Weinberg RS, Burkholder BB, Srikumaran D, Lee BS.

Am J Ophthalmol. 2013 Nov;156(5):1069-70. doi: 10.1016/j.ajo.2013.07.010. No abstract available.

PMID:
24138754
Items per page

Supplemental Content

Loading ...
Write to the Help Desk